Abstract
Aims - The present report was aimed at finding out whether gammaglobulin could have a role in treating ocular Behçet's disease (BD) refractory to accepted medical therapy. Methods - Six eyes of four patients with ocular BD refractory to steroids and cyclosporin A were treated with a course of intravenous gammaglobulin and followed up for their response to treatment. Results - All six eyes of all four patients showed good response to gammaglobulin therapy. Conclusion - Gamma globulin may have a role in treating refractory ocular BD. A wide range of controlled studies with longer follow up is needed to substantiate this impression.
| Original language | English |
|---|---|
| Pages (from-to) | 1287-1288 |
| Number of pages | 2 |
| Journal | British Journal of Ophthalmology |
| Volume | 85 |
| Issue number | 11 |
| DOIs | |
| State | Published - 2001 |
| Externally published | Yes |
ASJC Scopus subject areas
- Ophthalmology
- Sensory Systems
- Cellular and Molecular Neuroscience
Fingerprint
Dive into the research topics of 'Intravenous immunoglobulin therapy for resistant ocular behçet's disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver